105365-50-2Relevant academic research and scientific papers
Aryl trihydroxyborates: Easily isolated discrete species convenient for direct application in coupling reactions
Cammidge, Andrew N.,Goddard, Victoria H. M.,Gopee, Hemant,Harrison, Nicola L.,Hughes, David L.,Schubert, Christopher J.,Sutton, Benjamin M.,Watts, Gary L.,Whitehead, Andrew J.
, p. 4071 - 4074 (2006)
A conceptually and practically simple alternative approach to the use of arylboron species as the organometallic component in cross-coupling processes is described whereby trihydroxyborate salts are isolated and directly employed. The protocol derives practical benefit from the ease and convenience of the isolation and subsequent use of the discrete borate salts, eliminates the need for additional base, and aids the use of correct reaction stoichiometry.
Composition for organic electroluminescent element, organic electroluminescent element, display and lighting
-
Page/Page column 201, (2018/03/25)
The invention relates to a composition for organic electroluminescent element, which comprises: a solvent; and a compound group α for organic electroluminescent element that is constituted of at least two kinds of compounds which each have a molecular weight of 3,000 or less and have a structure comprising a plurality of aromatic ring groups linked to each other, wherein the compound group α comprises: a compound α1; and another compound αn satisfying a specific condition.
A green, efficient, and rapid procedure for the hydrogenation of nitroarenes to formanilides in water
Wang, Yingying,Zhan, Zhajun,Zhou, Yang,Lei, Min,Hu, Lihong
, p. 527 - 533 (2018/01/27)
Abstract: A green, efficient, and rapid procedure for the hydrogenation of nitroarenes to formanilides in Pd(TFA)2/HCOOH system in water is described. Under optimized conditions, the reaction of most substrates is complete within 30?min with yields of 30–93%. Furthermore, this procedure is applied successfully for the modification of natural products, such as arctigenin, vindoline, and estrone. Graphical abstract: [Figure not available: see fulltext.].
Cyanopyrimidine derivatives
-
Page/Page column 98, (2018/05/15)
The present invention relates to compounds of formula Min which R M has the meaning indicated in claim 1, to liquid crystal mixture comrising the same, to the use of these liquid-crystal media, in particular in components for high-frequency technology, and to components of this type which contain media according to the invention, and to the production and use of these components. The components according to the invention are suitable, in particular, as phase shifters in the microwave and millimetre wave region, for microwave and millimetre wave array antennae and very particularly for so-called tunable reflectarrays .
Organometallic complex, organometallic complex-containing composition, light-emitting material, organic electroluminescent element material, organic electroluminescent element, and an organic EL display EL lighting org.
-
Paragraph 0151; 0152; 0153, (2018/12/01)
PROBLEM TO BE SOLVED: To provide organic metal complexes that can retain high performance in life, durability and the like of organic electroluminescent elements. SOLUTION: An iridium complex obtained from a 2-(3'-biphenyl)-pyridine derivative in which a pyridine group and/or a phenyl group at 3'-position has at least one ≥5C alkyl group as a substituent is provided. The iridium complex, for example, is an iridium complex D-3 synthesized by the reaction formula. COPYRIGHT: (C)2010,JPOandINPIT
ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL, COMPOSITION CONTAINING SAID COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE
-
Paragraph 0377, (2014/03/21)
The invention provides an organic compound incorporating a specific structure into a pyridine skeleton or a 1,3,5-triazine skeleton and adapting the molecular weight to a specific range, a composition comprising the organic compound and a solvent, organic electroluminescent element comprising a layer that is formed by using the composition, and the uses thereof.
PHENYL BICYCLIC METHYL AZETIDINE DERIVATIVES AS SPHINGOSINE-1 PHOSPHATE RECEPTORS MODULATORS
-
Page/Page column 7, (2012/10/23)
The present invention relates to novel phenyl bicyclic methyl azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
AROMATIC COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHONATE (S1P) RECEPTOR ACTIVITY
-
Page/Page column 7-8, (2011/11/30)
Novel aromatic compounds which are useful as sphingosine-1-phosphate modulators and useful for treating a wide variety of disorders associated with modulation of sphingosine-1-phosphate receptors.
Microwave accelerated synthesis and evaluation of conjugated oligomers based on 2,5-di-thiophene-[1,3,4]thiadiazole
McCairn, Mark C.,Kreouzis, Theo,Turner, Michael L.
experimental part, p. 1999 - 2006 (2010/09/04)
A series of π-conjugated 2,5-di-thiophene-[1,3,4]thiadiazole based pentamers have been synthesised by microwave promoted palladium catalysed cross-coupling reactions. The aromatic groups that terminate each pentamer have a profound effect on the observed optical, electrochemical and liquid crystalline properties. Substitution of progressively less electron rich aromatic groups at the periphery of the pentamers decreased the energy gap between the ground state and the first excited state and also lowered the energy of the frontier orbitals sufficiently to impede oxidation and facilitate reduction. The thermotropic calamitic mesogen, 2,5-bis-[5-(4-hexyl-phenyl)- thiophen-2-yl]-[1,3,4]thiadiazole, 7 showed non-dispersive ambipolar charge transport in the nematic, smectic and crystalline phases. The charge mobility increased concomitantly with increasing molecular order of the mesophase to a maximum in the highest ordered smectic phase (hole ≈ 4 × 10-3 cm2 V-1 s-1, electron ≈ 8 × 10-3 cm2 V-1 s-1).
BI-ARYL COMPOUND HAVING IMMUNOSUPPRESSIVE ACTIVITY
-
Page/Page column 91; 92, (2010/02/10)
The invention is directed to a bi-aryl compound having a unique immunomodulating activity, a process for a preparation thereof, a pharmaceutical composition containing the same, and a method of preventing or treating disorders or diseases mediated by T lymphocytes by administering the compound to a subject in need of treatment.
